MOTS-c 20mg
€ 89,00
MOTS-C 20 mg – Grail Formula Quality.
Researched and verified with Liquilabs s.r.o. Czechia.
Analytical testing confirms 99.4 % purity, assay content verified at 22.3 mg and endotoxin levels below 0.001 EU/mg.
Supplied as a 20 mg lyophilized peptide with full COA traceability.
For research use only — not for human or veterinary use.
Availability: In stock: ships within 1 day after payment confirmation.
For research use only — not for human or veterinary use.
Analytical Verification (COA)
Each batch of MOTS-C supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.
Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.
Batch: GF-MOTSC20-B241
Key analytical results include:
- Assay Content: 22.3 mg
- Identification – Retention Time: 0.985
- Identification – Spectrum: 993
- Purity: 99.4 percent
- Bacterial Endotoxins: below 0.001 EU per mg
- Total Aerobic Microbial Count: not detected
- Total Yeast and Mold Count: not detected
Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.
These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.
Product Overview
MOTS-C is a mitochondrial-derived peptide studied in controlled laboratory environments focused on metabolic signalling pathways and cellular regulatory systems.
The compound is commonly investigated in biochemical research for its interaction with intracellular signalling networks and mitochondrial-associated processes.
This preparation contains 20 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute it for controlled in vitro experimentation.
Due to its defined structure and mitochondrial origin, MOTS-C is frequently referenced in experimental metabolic and cellular research models.
Compound Overview
MOTS-C is a peptide derived from mitochondrial DNA, studied in biochemical research for its role in cellular signalling and metabolic regulation.
Within experimental models, it is commonly investigated for its interaction with intracellular pathways and energy-related signalling systems.
Because of its defined molecular profile, the compound is frequently used in laboratory studies examining metabolic signalling and cellular regulation.
Historical Background and Scientific Context
Scientific interest in mitochondrial-derived peptides has increased with advances in cellular biology and metabolic research.
Peptides such as MOTS-C have been studied to better understand mitochondrial signalling and intracellular regulatory mechanisms.
This has contributed to broader research into metabolic regulation and peptide-mediated cellular processes.
Mechanistic Focus in Research
Within experimental laboratory settings, MOTS-C is commonly studied in relation to mitochondrial signalling and metabolic regulatory pathways.
Research investigations commonly explore the compound in experimental models examining:
- Mitochondrial signalling pathways
- Cellular energy regulation mechanisms
- Intracellular signalling networks
- Metabolic pathway interactions
- Comparative peptide research
- Molecular signalling pathway analysis
- Regulatory interaction modelling
These experimental models allow scientists to investigate molecular mechanisms involved in metabolic signalling and cellular regulation.
Research Applications
In controlled research environments, MOTS-C may be utilised in experimental models designed to explore mitochondrial signalling systems and metabolic pathways.
Examples of research applications include:
- Metabolic pathway investigation
- Mitochondrial signalling research
- Cellular energy regulation studies
- Intracellular signalling modelling
- Comparative peptide studies
- Molecular pathway analysis
- Controlled in vitro research
Grail Formula Quality
Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.
Each batch undergoes independent analytical testing to verify:
- Compound identity
- Assay accuracy
- Purity confirmation
- Microbial safety
- Endotoxin levels
- Heavy metal screening
- Full batch traceability
All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.
Research Use Limitation
- Used solely for in vitro experiments
- Not permitted for clinical trials involving humans
- Not permitted for human or veterinary administration
- Not permitted for investigational human use
- Independently analysed by Liquilabs s.r.o. Czechia
- 99.4 % purity confirmed by COA
- Assay content verified at 22.3 mg
- Endotoxin level below 0.001 EU/mg
- No detectable heavy metals or microbial contamination
- Mitochondrial-derived peptide for laboratory research
- For research use only – not for human or veterinary use
For laboratory research only. Not intended for human consumption, injection, or cosmetic use.
This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.




